September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Helicobacter Pylori and Type 2 Diabetes Mellitus: More GI Upset with Metformin
May 12th 2015China's type 2 diabetes mellitus (T2DM) epidemic continues to be a pervasive, costly health care issue, with proportions surpassed only by epidemic here in the US. The majority of T2DM treatment guidelines recommend metformin as the first-line anti-hyperglycemic agent for diabetes management due to its relative safety, tolerability, and cost-effectiveness.
Diabetes Diagnosis Opens a Window of Opportunity for Weight Loss
May 5th 2015When patients are initially diagnosed with type 2 diabetes, clinicians usually recommend several lifestyle changes, including weight loss. Few studies have looked at weight changes in patients with type 2 diabetes around initial diagnosis, although it's clear that it is more difficult for patients with diabetes to lose weight than it is for others.
Liver Meeting Draws 11,000 to Vienna
An estimated 11,000 attendees from 105 countries are converging in Vienna, Austria for the 50th International Liver Congress, hosted by the European Association for the Study of the Liver (ILC/EASL). Some 200 journalists -- including a team from MD Magazine--are on hand to report the news. Eagerly awaited trials include those of two drugs that show promise for treating a common liver disease associated with obesity, known medically as non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).
Diet & Diabetes Prevention: Does the Specific Diet Matter?
April 22nd 2015The American Diabetes Association recommends eating fewer calories of better quality to prevent diabetes. Researchers looked at the available evidence from studies that examined a variety of diets and found that any healthy diet reduces the risk of diabetes by about 20%.
Denosumab: Can RANKL Inhibition Improve Insulin Resistance?
April 22nd 2015With more than 40 million Americans either diagnosed or at high risk for osteoporosis as they age, researchers are scrambling to find ideal preventive and curative agents. One target that strengthens bones is excessive osteoclast activity. A team of researchers recently found that one biologic that targets excessive osteoclast activity may positively influence another problem of later life: insulin sensitivity.
Glycated Albumin: The Next HgA1c?
April 15th 2015Albumin -- the most abundant protein in the human body -- has many roles. It transports hormones, fatty acids, and other compounds. It buffers serum pH, and maintains osmotic pressure. Now, it appears that albumin may be a tool that could be used in diabetes management.
Genetics May Control Gabapentin Response
Gabapentin is used to treat neuropathic pain from several causes, including diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain. In a study presented at the American Society of Interventional Pain Physicians in Orlando, FL, April 11, Tobore Onojighofia, MD, MPH and colleagues found genetics plays a role in which patients do well on the drug.
FDA Panel Recommends Adding New Safety Warnings to Labels of 3 Diabetes Drugs
An advisory panel for the US Food and Drug Administration (FDA) held a hearing yesterday focusing on safety issues associated with two diabetes medications. Although the panel's recommendation did not include specific treatment changes, its decision highlighted the fact that more research is needed on cardiovascular risk associated with this class of diabetes medications.
Chronic Kidney Disease: Sleep Problems Increases with Disease Progression
April 13th 2015Lack of sleep and chronic kidney disease (CKD) independently lead to hypertension, diabetes mellitus, lower quality of life, and shorter life expectancy. Severity of CKD and sleep disturbances may also worsen diabetes and hypertension synergistically.